Be part of the knowledge.™

Oncology and Hematology

1037

LikeLikedUnlike

16-30 of 360

MinuteCE®
Treatment Decisions That Matter: A Case-Based Discussion in Advanced Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 credits 5 episodes
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
MinuteCE®
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
MinuteCE®
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Ritu Salani, MD
1.00 program credits
advertisement
CME/CE Virtual Event
Targeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure
Multiple dates available
0.50 credits
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
CME/CE
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
- Alex F. Herrera, MD
1.00 credits
CME/CE Virtual Event
Closing the Gap in First-Line Treatment of KRAS G12C–Mutated Advanced NSCLC: From Biology to Bedside Decisions and Trial-Ready Care
Multiple dates available
0.75 credits
CME/CE In-Person & Virtual Event
The CELMoD Shift: Translating Protein Degradation Science Into Practice-Changing Myeloma Care
December 11, 2026
New Orleans, Louisiana
1.50 credits
CME/CE Virtual Event
Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
Multiple dates available
0.75 credits
MinuteCE®
Beyond Checkpoint Blockade in SCLC: Emerging Antigen Targets and Treatment Strategies Across Disease Stages
- Neal Ready, MD, PhD
- Ticiana Leal, MD
0.50 credits 4 episodes
advertisement
Translating Research Into Practice in Breast Cancer: Emerging Data and the Expanding Role of ADCs
CME/CE
Translating Research Into Practice in Breast Cancer: Emerging Data and the Expanding Role of ADCs
- Sara A. Hurvitz, MD, FACP
- Tiffany Traina, MD
0.50 credits
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
MinuteCE®
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough
- Neal Ready, MD, PhD
0.50 program credits
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
MinuteCE®
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC
- Neal Ready, MD, PhD
0.50 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended